CATALOGO DEI PRODOTTI DELLA RICERCA

FERDEGHINI, Marco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.040
EU - Europa 6.290
AS - Asia 5.397
SA - Sud America 589
AF - Africa 84
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 10
Totale 22.424
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.952
SG - Singapore 2.584
RU - Federazione Russa 2.139
CN - Cina 1.423
GB - Regno Unito 1.362
BR - Brasile 469
FI - Finlandia 466
FR - Francia 457
HK - Hong Kong 455
DE - Germania 453
VN - Vietnam 419
IT - Italia 392
IE - Irlanda 346
SE - Svezia 318
KR - Corea 192
UA - Ucraina 173
IN - India 62
AR - Argentina 42
BD - Bangladesh 42
CA - Canada 42
TR - Turchia 40
MX - Messico 33
ES - Italia 30
IQ - Iraq 26
JP - Giappone 25
BE - Belgio 24
PL - Polonia 24
EC - Ecuador 22
ID - Indonesia 22
ZA - Sudafrica 22
NG - Nigeria 21
NL - Olanda 21
AT - Austria 19
PK - Pakistan 16
CO - Colombia 15
VE - Venezuela 13
AE - Emirati Arabi Uniti 11
AU - Australia 11
EG - Egitto 10
MA - Marocco 10
CL - Cile 8
NP - Nepal 8
PS - Palestinian Territory 8
PY - Paraguay 8
SA - Arabia Saudita 8
MY - Malesia 7
PH - Filippine 7
RO - Romania 7
UZ - Uzbekistan 7
DK - Danimarca 6
EU - Europa 6
KE - Kenya 6
KZ - Kazakistan 6
LT - Lituania 6
UY - Uruguay 5
AZ - Azerbaigian 4
BG - Bulgaria 4
CZ - Repubblica Ceca 4
HR - Croazia 4
HU - Ungheria 4
JO - Giordania 4
PE - Perù 4
RS - Serbia 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AL - Albania 3
BA - Bosnia-Erzegovina 3
BY - Bielorussia 3
DO - Repubblica Dominicana 3
IL - Israele 3
JM - Giamaica 3
TH - Thailandia 3
BO - Bolivia 2
CH - Svizzera 2
CI - Costa d'Avorio 2
DZ - Algeria 2
EE - Estonia 2
GT - Guatemala 2
LB - Libano 2
LI - Liechtenstein 2
LU - Lussemburgo 2
LV - Lettonia 2
NZ - Nuova Zelanda 2
PA - Panama 2
PT - Portogallo 2
SI - Slovenia 2
TN - Tunisia 2
AM - Armenia 1
AO - Angola 1
BH - Bahrain 1
BN - Brunei Darussalam 1
CG - Congo 1
CM - Camerun 1
CU - Cuba 1
CY - Cipro 1
DJ - Gibuti 1
ET - Etiopia 1
GA - Gabon 1
GE - Georgia 1
GY - Guiana 1
IR - Iran 1
Totale 22.406
Salva come PNG Salva come JPEG
Città #
Jacksonville 1.639
Singapore 1.523
Ashburn 1.171
Southend 1.106
Chandler 1.036
Woodbridge 844
San Jose 640
Ann Arbor 589
Moscow 586
Dallas 568
Hong Kong 449
Houston 412
Dublin 342
The Dalles 328
Verona 232
Wilmington 188
Lawrence 184
Princeton 184
Nanjing 143
Beijing 141
Ho Chi Minh City 139
Sindelfingen 131
Los Angeles 130
New York 128
Boardman 111
Buffalo 99
Helsinki 94
Jinan 90
Shenyang 88
Hebei 85
Hanoi 80
Tianjin 70
Philadelphia 59
Changsha 56
Santa Clara 48
Nanchang 46
Detroit 45
São Paulo 43
Columbus 42
Hangzhou 41
Zhengzhou 40
Milan 39
Haikou 37
Jiaxing 37
Dong Ket 36
Norwalk 35
Ningbo 34
Munich 33
Guangzhou 30
Chicago 26
Orem 25
Redondo Beach 25
Brussels 24
Falls Church 24
Taizhou 22
Tokyo 22
San Francisco 21
Washington 21
Abuja 20
Bologna 20
Toronto 19
Warsaw 19
Auburn Hills 17
Frankfurt am Main 17
Lanzhou 17
Chennai 16
Rio de Janeiro 16
Taiyuan 16
Brooklyn 15
Dearborn 15
Lancaster 15
Tappahannock 15
Da Nang 14
Seattle 14
Stockholm 14
Düsseldorf 13
London 13
Montreal 13
Phoenix 13
Shanghai 13
Turku 13
Atlanta 12
Bắc Ninh 11
Haiphong 11
Vienna 11
Amsterdam 10
Biên Hòa 10
Council Bluffs 10
Johannesburg 10
Manchester 10
Mexico City 10
Redwood City 10
Baghdad 9
Istanbul 9
Seoul 9
Shenzhen 9
Boston 8
Buenos Aires 8
Cairo 8
Charlotte 8
Totale 15.001
Salva come PNG Salva come JPEG
Nome #
[111In-DTPA-D-Phe]-octreotide scintigraphy in functioning and non-functioning pituitary adenomas 257
A Case Report of Insulinoma Relapse on Background Nesidioblastosis: A Rare Cause of Adult Hypoglycemia 249
Gated reconstruction in 18FDG PET-CT quantitative imaging: impact on SUV estimation in lung tumors 215
First human Cerenkography. 209
SU-E-J-168: 4D-PET for Target Volume Delineation in Respiratory-Gated Radiation Therapy. 208
A mathematical model of thyroid mass reduction after radioiodine therapy of Graves’ disease 207
Humanization of care in pediatrics and built-in psychological support in nuclear medicine [Umanizzazione delle cure in età pediatrica e assistenza psicologica integrata in Medicina nucleare] 202
Espressione di Claudina-1 e 7 nel carcinoma papillare della tiroide con comportamento clinico aggressivo 196
Role of dual-point FDG PET/CT in prone position and fused PET/MR; correlation with biologic prognostic parameters in breast cancer 192
Predictive factors of efficacy of the somatostatin analogue octreotide as first line therapy for advanced pancreatic endocrine carcinoma. 189
Correlation between intracoronary physiology and myocardial perfusion imaging in patients with severe aortic stenosis 184
rhTSH-Stimulated Postsurgical Thyroid Remnant Ablation in Differentiated Thyroid Cancer: 1.85 vs 3.7 GBq I-131 Activity 183
Break-apart interphase fluorescence in situ hybridization assay in papillary thyroid carcinoma: on the road to optimizing the cut-off level for RET/PTC rearrangements 181
Valutazione comparativa dell'acquisizione volumetrica tiroidea con ecografia convenzionale B-Mode (US) ed ecografia volumetrica (VUS) 179
A comparison of pretreatment serum levels of four tumor markers in patients with endometrial and cervical carcinoma 177
Comparison between remnant and red-marrow absorbed dose in thyroid cancer patients submitted to 131I ablative therapy after rh-TSH stimulation versus hypothyroidism induced by L-thyroxine withdrawal. 177
A comparative evaluation of the ability of serum CA 125, CA 19-9, CA 15-3, CA 50, CA 72-4 and TATI assays in reflecting the course of disease in patients with ovarian carcinoma 176
A new luminescence immunoassay for thyrotropin using coated tubes: evaluation and comparison with immunoradiometric assay 176
Acute suppression of parathyroid activity during hemofiltration 171
RET mutation and increased angiogenesis in medullary thyroid carcinomas 170
[Primary empty sella syndrome. Clinical and radiological study, and evaluation of pituitary function] 169
A comparison of the usefulness of serum measurements of CA 125, CA 50 and TATI in patients with malignant and benign gynecological pathology 168
A Dirichlet process mixture model for automatic (18)F-FDG PET image segmentation: Validation study on phantoms and on lung and esophageal lesions 165
Effect of somatostatin infusion on the somatotrope responsiveness to growth hormone-releasing hormone in patients with anorexia nervosa. 163
Optimized PET Imaging for 4D Treatment Planning in Radiotherapy: the Virtual 4D PET Strategy 163
Analytical and clinical assessment of a commercial kit for the simultaneous determination of free thyroxine and thyrotropin 160
A new human chromogranin 'A' immunoradiometric assay for the diagnosis of neuroendocrine tumours 159
Age and Gender Substantially Influence the Relationship Between Thyroid Status and the Lipoprotein Profile: Results from a Large Cross-Sectional Study. 159
Multidisciplinary approach including receptor radionuclide therapy with 90Y-DOTATOC ([90Y-DOTA0, Tyr3]-octreotide) and 177Lu-DOTATATE ([177Lu-DOTA0, Tyr3]-octreotate) in ectopic cushing syndrome from a metastatic gastrinoma: a promising proposal. 157
[Growth factors and oncogenes in development and carcinogenesis. Role of the epidermal growth factor system] 156
[Bromocriptine therapy from the 2d month of pregnancy induces regression of neuro-ophthalmologic complications caused by macroprolactimona] 155
[Serum levels of CA 125, CA 19-9, TPA, CEA and CA 50: useful evaluation parameters in the diagnosis of ovarian cancer] 149
Serum CYFRA 21-1 assay in squamous cell carcinoma of the cervix 146
[Tumor markers: new prospects in the diagnosis and clinical monitoring of malignant epithelial neoplasms of the ovary] 144
Comparison of plasma and urinary methods for the direct measurement of the thyroxine to 3,5,3' - triiodothyronine conversion rate in man 144
Lazaroid U-74389F attenuates phorbol ester-induced lung injury in rabbits 141
Relation of fetal growth to maternal responses to oral glucose tolerance test throughout gestation 140
CAM26, CAM29 and mucin-like carcinoma associated antigen in epithelial ovarian cancer 139
Clinical validation of the new ELSA-CA 125 II assay: report of a European multicentre evaluation 138
Chromosome translocation frequency after radioiodine thyroid remnant ablation: a comparison between rhTSH stimulation and prolonged levothyroxine withdrawal. 138
Functional Imaging and Peptide Receptor Radionuclide Therapy 137
A computer program for customized recommendations to radioiodine-treated patients [Studio e realizzazione di un programma computerizzato per prescrizioni personalizzate a pazienti iodiotrattati in dimissione] 136
Serum interleukin-6 levels in uterine malignancies. Preliminary data 135
Blood markers of early and late airway responses to allergen in asthmatic subjects. Relationship with functional findings 134
Serum levels of tumor necrosis factor (TNF), soluble receptors for TNF (55- and 75-kDa sTNFr), and soluble CD14 (sCD14) in epithelial ovarian cancer 134
[Serum CA125, CA19-9 and TPA in the diagnostic approach to neoplastic pathology of the ovary] 133
Tumor-associated trypsin inhibitor (TATI) and renal function 132
[Comparison of serum determinations of CA125, CA15-3 and CA50 in the preoperative evaluation of adnexal tumors] 132
Final height, gonadal function and bone mineral density of adolescent males with central precocious puberty after therapy with gonadotropin-releasing hormone analogues. 131
Plasma leptin levels in newborns from normal and diabetic mothers. 131
Preoperative evaluation of D-dimer and CA 125 levels in differentiating benign from malignant ovarian masses 130
Off-Label Use of Sunitinib in Patients with Advanced, Epithelial Thyroid Cancer: A Retrospective Analysis. 129
Determination of serum levels of different cytokeratins in patients with uterine malignancies 128
Combined evaluation of some tumor associated antigens in the monitoring of integrated surgical and chemotherapeutic treatment of epithelial ovarian cancer 128
CA 195: a new monoclonal antibody-defined Lea blood group-related tumor marker in patients with epithelial ovarian cancer 127
Comparison of tumor-associated trypsin inhibitor (TATI) with CA125 as a marker for diagnosis and monitoring of epithelial ovarian cancer 127
Effect of anabolic treatment on the serum levels of gonadotropins, testosterone, prolactin, thyroid hormones and myoglobin of male athletes under physical training 127
The relationship between maternal relaxation and plasma beta-endorphin levels during parturition 126
Radioimmunoassay of unconjugated and total serum estetrol using a 125I-iodinated tracer 126
T-helper 1 and 2 activation with fresh or cultured allo- or xenoislets 125
Carcinoid crisis induced by receptor radionuclide therapy with 90Y-DOTATOC in a case of liver metastases from bronchial neuroendocrine tumor (atypical carcinoid). 125
Autonomous thyroid nodule and percutaneous ethanol injection [letter] [see comments] 124
Serum tumour-associated trypsin inhibitor (TATI) and renal function 123
Hypothalamo-pituitary function in four cases of true precocious puberty 123
Anomalous between-laboratory variability in a collaborative study of carcinoembryonic antigen immunoassay [letter] 122
Can insulin action induce myocardial texture alterations in essential hypertension? 122
Comparison between serum CA 125 and CA 19-9 assays and tissular OC 125 and 1116NS 19-9 reactivity in malignant and benign ovarian tumors 121
Blockade of cholinergic muscarinic receptors by pirenzepine and GHRH-induced GH secretion in the acute and recovery phase of anorexia nervosa and atypical eating disorders 121
Preoperative serum intercellular adhesion molecule-1 (ICAM-1) and E-selectin (endothelial cell leukocyte adhesion molecule, ELAM-1) in patients with epithelial ovarian cancer 120
Correlation of CA125 and CA19-9 serum levels with clinical course and second-look findings in patients with ovarian carcinoma 120
Serum anti-p53 antibodies in the follow-up of patients with advanced ovarian carcinoma 119
Preoperative D-dimer plasma assay is not a predictor of clinical outcome for patients with advanced ovarian cancer 119
The measurement of plasma D-dimer (DD) levels in the follow-up of patients with ovarian cancer 119
Comet assay on children's leukocytes 8 years after the Chernobyl disaster 119
Plasma cholesterol regulates soluble cell adhesion molecule expression in familial hypercholesterolemia 119
External quality control survey for alpha-fetoprotein assay 119
Effects of the ablation of the submaxillary gland on the rat testis 118
Relationship between the circulating levels of adenohypophyseal hormones in blood and in cerebrospinal fluid 118
Preoperative serum E-cadherin assay in patients with ovarian carcinoma 117
The trend of serum CA125 levels during the first three courses of chemotherapy as a predictor of second-look findings in patients with ovarian carcinoma 117
Assessment of tumor-associated trypsin inhibitor (TATI) as a marker of renal function. 117
Serum preoperative vascular endothelial growth factor (VEGF) in epithelial ovarian cancer: relationship with prognostic variables and clinical outcome. 117
The concomitant determination of different tumor markers in patients with epithelial ovarian cancer and benign ovarian masses: relevance for differential diagnosis 116
Hyperprolactinemic amenorrhea induced by an intrasellar epithelial cyst 116
Clinical experience with recombinant human thyrotrophin (rhTSH) in the management of patients with differentiated thyroid cancer. 116
Somatotropic axis and body weight in pre-menopausal and post-menopausal women: evidence for a neuroendocrine derangement, in absence of changes of insulin-like growth factor binding protein concentrations 115
Role of neck ultrasonography in the follow-up of patients operated on for thyroid cancer 114
Combined use of CA 125 and CA 15-3 in patients with endometrial carcinoma 114
Role of serum carrier proteins in the peripheral metabolism and tissue distribution of thyroid hormones in familial dysalbuminemic hyperthyroxinemia and congenital elevation of thyroxine-binding globulin 114
Human seminal transferrin: correlation with seminal and hormonal parameters 114
Long-term quiescence of ectopic Cushing's syndrome caused by pulmonary neuroendocrine tumor (typical carcinoid) and tumorlets: spontaneous remission or therapeutic effect of bromocriptine? 114
Soluble interleukin-2 receptor release during culture of human lymphocytes with human, porcine, or bovine islets and the effect of culture and cryopreservation 113
Differential diagnosis of adnexal masses with transvaginal sonography, color flow imaging, and serum CA 125 assay in pre- and postmenopausal women 113
Serum soluble interleukin-2 receptor assay in epithelial ovarian cancer 113
Severe leukopenia and mild thrombocytopenia after chronic bromocriptine (CB-154) administration 113
High-performance liquid chromatographic separation of iodoamino acids for tracer turnover studies of thyroid hormones in vivo 113
Circulating levels of IGF-I in patients with chronic uremia on conservative dietary treatment. 113
Anticlastogenic Effect of Ginkgo biloba Extract in Graves' Disease Patients Receiving Radioiodine Therapy 113
Pancreatic cancer and tumor markers: role of the newly identified CAR-3 antigen 112
The concomitant determination of different serum tumor markers in epithelial ovarian cancer: relevance for monitoring the response to chemotherapy and follow-up of patients 111
Totale 14.245
Salva come PNG Salva come JPEG
Categoria #
all - tutte 72.434
article - articoli 68.766
book - libri 0
conference - conferenze 2.519
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.149
Totale 144.868
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021285 0 0 0 0 0 0 0 0 0 5 201 79
2021/2022955 38 121 7 37 35 24 13 81 81 49 127 342
2022/20232.784 228 176 256 505 351 599 15 238 274 17 85 40
2023/20241.097 79 143 109 257 86 136 24 35 7 13 115 93
2024/20252.780 250 192 31 497 158 39 30 165 506 168 228 516
2025/20268.039 683 459 659 1.060 1.819 550 1.160 528 694 427 0 0
Totale 22.466